Management of cluster headache: Treatments and their mechanisms
Cephalalgia · 2023
DOI: 10.1177/03331024231196808 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cephalalgia, 2023. Verfasst von Kuan-Po Peng und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Systems Neuroscience, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. Hauptthemen laut MEDLINE: Cluster Headache, Drug-Related Side Effects and Adverse Reactions. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 165 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Will Erwin Headache Research Center.
Abstract (Originalsprache)
Background
The management of cluster headache is similar to that of other primary headache disorders and can be broadly divided into acute and preventive treatments. Acute treatments for cluster headache are primarily delivered via rapid, non-oral routes (such as inhalation, nasal, or subcutaneous) while preventives include a variety of unrelated treatments such as corticosteroids, verapamil, and galcanezumab. Neuromodulation is becoming an increasingly popular option, both non-invasively such as vagus nerve stimulation when medical treatment is contraindicated or side effects are intolerable, and invasively such as occipital nerve stimulation when medical treatment is ineffective. Clinically, this collection of treatment types provides a range of options for the informed clinician. Scientifically, this collection provides important insights into disease mechanisms.
Methods
Two authors performed independent narrative reviews of the literature on guideline recommendations, clinical trials, real-world data, and mechanistic studies.
Results
Cluster headache is treated with acute treatments, bridge treatments, and preventive treatments. Common first-line treatments include subcutaneous sumatriptan and high-flow oxygen as acute treatments, corticosteroids (oral or suboccipital injections) as bridge treatments, and verapamil as a preventive treatment. Some newer acute (non-invasive vagus nerve stimulation) and preventive (galcanezumab) treatments have excellent clinical trial data for episodic cluster headache, while other newer treatments (occipital nerve stimulation) have been specifically tested in treatment-refractory chronic cluster headache. Most treatments are suspected to act on the trigeminovascular system, the autonomic system, or the hypothalamus.
Conclusions
The first-line treatments have not changed in recent years, but new treatments have provided additional options for patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Systems Neuroscience, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
- Department of Neurosurgery, UTHealth Houston, Houston, Texas, USA.
ORCID-Profile: Kuan-Po Peng, Mark J Burish
Förderung
- Will Erwin Headache Research Center
Zitieren
APA
Peng, K. P., & Burish, M. J. (2023). Management of cluster headache: Treatments and their mechanisms. Cephalalgia. https://doi.org/10.1177/03331024231196808
Vancouver
Peng KP, Burish MJ. Management of cluster headache: Treatments and their mechanisms. Cephalalgia. 2023. doi:10.1177/03331024231196808
BibTeX
@article{Peng2023,
author = {Peng, Kuan-Po and Burish, Mark J},
title = {Management of cluster headache: Treatments and their mechanisms},
journal = {Cephalalgia},
year = {2023},
doi = {10.1177/03331024231196808}
}
EUVIMED